Nicolai Skovbjerg Arildsen

Nicolai Skovbjerg Arildsen

External, Ekstern

Member of:


    1. 2010
    2. Published

      In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection

      Gjetting, T., Arildsen, Nicolai Skovbjerg, Christensen, C. L., Poulsen, T. T., Roth, J. A., Handlos, V. N. & Poulsen, H. S., 9 Aug 2010, In: International Journal of Nanomedicine. 5, p. 371-83 13 p.

      Research output: Contribution to journalJournal articlepeer-review

    3. 2015
    4. Published

      Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival

      Jönsson, J., Arildsen, Nicolai Skovbjerg, Malander, S., Måsbäck, A., Hartman, L., Nilbert, M. & Hedenfalk, I., Oct 2015, In: Translational Oncology. 8, 5, p. 424-33 10 p.

      Research output: Contribution to journalJournal articlepeer-review

    5. 2017
    6. Published

      Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma

      Arildsen, Nicolai Skovbjerg, Jönsson, J., Bartuma, K., Ebbesson, A., Westbom-Fremer, S., Måsbäck, A., Malander, S., Nilbert, M. & Hedenfalk, I. A., 2017, In: Frontiers in Oncology. 7, 11 p., 109.

      Research output: Contribution to journalJournal articlepeer-review

    7. 2018
    8. Targeting Rho GTPases in ovarian clear cell cancer

      Arildsen, Nicolai Skovbjerg & Hedenfalk, I., Jul 2018.

      Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

    9. PD-1/PD-L1 EXPRESSION AND TUMOR-INFILTRATING LYMPHOCYTES ARE PROGNOSTICALLY FAVORABLE IN HIGH-GRADE SEROUS OVARIAN CANCER

      de la Fuente, L. M., Fremer, S. W., Arildsen, Nicolai Skovbjerg, Hartman, L., Malander, S., Kannisto, P., Masback, A. & Hedenfalk, I., Sep 2018, p. 761-761.

      Research output: Contribution to conferenceConference abstract for conferenceResearch

    10. 2019
    11. Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method

      Arildsen, Nicolai Skovbjerg, Martin de la Fuente, L., Måsbäck, A., Malander, S., Forslund, O., Kannisto, P. & Hedenfalk, I., 29 Oct 2019, In: Scientific Reports. 9, 1, p. 15506

      Research output: Contribution to journalJournal articlepeer-review

    12. 2020
    13. PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma

      Martin de la Fuente, L., Westbom-Fremer, S., Arildsen, Nicolai Skovbjerg, Hartman, L., Malander, S., Kannisto, P., Måsbäck, A. & Hedenfalk, I., 2020, In: Virchows Archiv. 477, p. 83–9

      Research output: Contribution to journalJournal articlepeer-review

    14. Published

      Simvastatin is a potential candidate drug in ovarian clear cell carcinomas

      Arildsen, Nicolai Skovbjerg & Hedenfalk, I., 2020, In: OncoTarget. 11, 40, p. 3660-3674 15 p.

      Research output: Contribution to journalJournal articlepeer-review

    15. 2021
    16. Published

      Epidermal biomarker levels differentiate lesional from non-lesional skin and show variation across anatomical locations in patients with atopic dermatitis

      Holm, J. G., Clausen, M., Agner, Tove, Arildsen, Nicolai Skovbjerg, Jakasa, I., Kezic, S. & Thomsen, Simon Francis, 2021, In: Journal of the European Academy of Dermatology and Venereology : JEADV. 35, 5, p. e325-e327

      Research output: Contribution to journalJournal articlepeer-review

    17. 2022
    18. Published

      Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study

      Noshela Ghazanfar, M., Bartko, E. A., Arildsen, Nicolai Skovbjerg, Poulsen, Lars K., Jensen, B. M., Enevold, C., Holm, J. G., Woetmann, Anders , Ødum, Niels & Thomsen, Simon Francis, 2022, In: Clinical and Experimental Allergy. 52, 4 p.

      Research output: Contribution to journalComment/debate

    Previous 1 2 Next

    ID: 227972192